Io Biotech

Developer of vaccine for the treatment of cancer

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2014 groups15 employees language iobiotech.com

Registered entities

Innovation

27 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 1,672 times.

YearFilings
20141
20162
20173
20187
201910
20208
20218
202215
20238
20249
202513
20263

Social engagement

Social engagement: 10K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

22 investors on record; lead investors include Sunstone, HBM Healthcare Investments, Lundbeck Foundation, Novo Holdings; 1 has since exited.

Investor typeCountShare
Venture capital732%
Private equity732%
Bank & private debt15%
Other / undisclosed732%

Recent activity

19 Dec 2025
Event
partnership and investor meetings
3 Dec 2025
Event
ESMO Immuno-Oncology Congress 2025
26 Nov 2025
Event
8th Annual Evercore Healthcare Conference
Coming soon